Combining Osimertinib With Chemotherapy in EGFR-Mutant NSCLC at Progression. White MN, Piotrowska Z, Stirling K, Liu SV, et al. Clin Lung Cancer 2021;22:201-209.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

White MN, Piotrowska Z, Stirling K, Liu SV, et al. Combining Osimertinib With Chemotherapy in EGFR-Mutant NSCLC at Progression. Clin Lung Cancer 2021;22:201-209.
PMID: 33610453